127 related articles for article (PubMed ID: 38403542)
1. TSPAN6 could serve as a prognostic biomarker for patients with glioma.
Zeng X; Xie Y; Xie Y; Zhang C
Asian J Surg; 2024 May; 47(5):2250-2252. PubMed ID: 38403542
[No Abstract] [Full Text] [Related]
2. Long non-coding RNAs in glioma progression.
Xi J; Sun Q; Ma L; Kang J
Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
[TBL] [Abstract][Full Text] [Related]
3. Editorial commentary on "Analysis of IDH mutation, 1p19q deletion, and PTEN loss delineates prognosis in clinical low-grade gliomas".
Jenkins RB
Neuro Oncol; 2014 Jul; 16(7):891-2. PubMed ID: 24861880
[No Abstract] [Full Text] [Related]
4. TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating STAT3 signaling pathway.
Zhang C; Du FH; Wang RX; Han WB; Lv X; Zeng LH; Chen GQ
Int J Biol Sci; 2024; 20(7):2440-2453. PubMed ID: 38725860
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
6. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
7. RAB34 was a progression- and prognosis-associated biomarker in gliomas.
Wang HJ; Gao Y; Chen L; Li YL; Jiang CL
Tumour Biol; 2015 Mar; 36(3):1573-8. PubMed ID: 25501506
[TBL] [Abstract][Full Text] [Related]
8. Human TERT promoter mutations as a prognostic biomarker in glioma.
Powter B; Jeffreys SA; Sareen H; Cooper A; Brungs D; Po J; Roberts T; Koh ES; Scott KF; Sajinovic M; Vessey JY; de Souza P; Becker TM
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1007-1017. PubMed ID: 33547950
[TBL] [Abstract][Full Text] [Related]
9. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
Wang L; Wu L; Wu J
J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
16. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.
Pan SJ; Wu YB; Cai S; Pan YX; Liu W; Bian LG; Sun B; Sun QF
Biochem Biophys Res Commun; 2015 Mar; 458(3):476-482. PubMed ID: 25680464
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
20. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]